Cyclacel Pharmaceuticals Provides Update on Its Clinical Development Plan of Sapacitabine for Myelodysplastic Syndromes (MDS)
Source: Medical News (via PRIMEZONE) - Category: Pharmaceuticals Source Type: news
More News: Myelodysplastic Syndrome | Pharmaceuticals